Table 1.
Expression ratio | Non-sensitized | Untreated HDM-sensitized | MM ASO HDM-sensitized | COX-2 ASO HDM-sensitized |
mPGE synthase/GAPDH | 1.105 ± 0.09 | 1.047 ± 0.09 | 1.068 ± 0.13 | 0.624 ± 0.13* |
hPGD synthase/GAPDH | 0.369 ± 0.06 | 0.417 ± 0.06 | 0.335 ± 0.05 | 0.365 ± 0.06 |
a mRNA expression was analyzed by conventional reverse transcriptase-polymerase chain reaction and the expression ratios compared with GAPDH were determined by densitometry. No differences were observed in hPGD synthase mRNA expression, either between non-sensitized and sensitized animals or between HDM-sensitized animals treated with mismatched antisense oligonucleotides and animals treated with COX-2 antisense oligonucleotide. In contrast, mPGE synthase expression was reduced in the selective COX-2 oligonucleotide-treated mice compared with the other experimental groups. Data are shown as the mean ± SEM (*p< 0.05). ASO, antisense oligonucleotide; MM, mismatched oligonucleotide (n = 12).